Search results for "XY"

showing 10 items of 13736 documents

CCDC 268245: Experimental Crystal Structure Determination

2005

Related Article: V.Rudzevich, D.Schollmeyer, D.Braekers, J.F.Desreux, R.Diss, G.Wipff, V.Bohmer|2005|J.Org.Chem.|70|6027|doi:10.1021/jo050717a

tris(2-allyloxy-5-nitrophenyl)methaneSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 942549: Experimental Crystal Structure Determination

2015

Related Article: Christina Lohoelter, Malte Brutschy, Daniel Lubczyk and Siegfried R. Waldvogel|2013|Beilstein J.Org.Chem.|9|2821|doi:10.3762/bjoc.9.317

tris(31013a-trimethyl-10-((pent-4-en-1-yloxy)carbonyl)-123899a1011121313a13b-dodecahydro-37b-methanonaphtho[1'2':67]cyclohepta[12-b]pyrazine-56-diyl)-15:2016:1917:18-triptyceneSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 644918: Experimental Crystal Structure Determination

2008

Related Article: F.Durola, L.Russo, J.-P.Sauvage, K.Rissanen, O.S.Wenger|2007|Chem.-Eur.J.|13|8749|doi:10.1002/chem.200700684

tris(88'-bis(4-Methoxyphenyl)-33'-biisoquinoline-NN')-ruthenium(ii) bis(hexafluorophosphate) acetone solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1551425: Experimental Crystal Structure Determination

2018

Related Article: Eleni C. Mazarakioti, Sofia Tzani, Vassilis Psycharis, Michael Pissas, Yiannis Sanakis, Catherine P. Raptopoulou|2017|Curr.Inorg.Chem.|7|66|doi:10.2174/1877944107666170914113838

tris(mu-1-[{[1-hydroxy-2-(hydroxymethyl)-3-oxidopropan-2-yl]imino}methyl]naphthalen-2-olato)-tris(mu-benzoato)-tri-iron(iii) dichloromethane solvate hydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 910884: Experimental Crystal Structure Determination

2014

Related Article: Màrius Tarrés, Clara Viñas, Ana M. Cioran, Mikko M. Hänninen, Reijo Sillanpää, Francesc Teixidor|2014|Chem.-Eur.J.|20|15808|doi:10.1002/chem.201403424

tris(mu-acetone)-bis(55'-4-(2-[2-(dioxidan-2-id-1-yl)ethoxy]ethoxy)butyl)-11'-commo-(1-ferro-23-dicarba-closo-dodecaborane(10))-(1'-ferro-2'3'-dicarba-closo-dodecaborane(10))-di-sodiumSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1847233: Experimental Crystal Structure Determination

2019

Related Article: Md. Kamal Hossain, Jörg A. Schachner, Matti Haukka, Nadia C. Mösch-Zanetti, Ebbe Nordlander, Ari Lehtonen|2019|Inorg.Chim.Acta|486|17|doi:10.1016/j.ica.2018.10.012

tris(mu-oxido)-tris(24-di-t-butyl-6-{[(3-hydroxy-2-oxidopropyl)(methyl)amino]methyl}phenolato)-tri-molybdenum chloroform solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Data from: Parasitic wasp-associated symbiont affects plant-mediated species interactions between herbivores

2018

Microbial mutualistic symbiosis is increasingly recognised as a hidden driving force in the ecology of plant–insect interactions. Although plant‐associated and herbivore‐associated symbionts clearly affect interactions between plants and herbivores, the effects of symbionts associated with higher trophic levels has been largely overlooked. At the third‐trophic level, parasitic wasps are a common group of insects that can inject symbiotic viruses (polydnaviruses) and venom into their herbivorous hosts to support parasitoid offspring development. Here, we show that such third‐trophic level symbionts act in combination with venom to affect plant‐mediated interactions by reducing colonisation o…

tritrophic interactionsfungifood and beveragesPieris brassicaeplant-insect interactionsPE&RCLaboratorium voor EntomologieLife sciencespolydnavirusesmedicine and health careCgBVherbivore colonizationMedicineBrassica oleraceaPlutella xylostellaEPSLaboratory of EntomologyCotesia glomerataparasitoid
researchProduct

On the mechanism of imine elimination from Fischer tungsten carbene complexes

2016

(Aminoferrocenyl)(ferrocenyl)carbene(pentacarbonyl)tungsten(0) (CO)5W=C(NHFc)Fc (W(CO)5(E-2)) is synthesized by nucleophilic substitution of the ethoxy group of (CO)5W=C(OEt)Fc (M(CO)5(1Et)) by ferrocenyl amide Fc-NH– (Fc = ferrocenyl). W(CO)5(E-2) thermally and photochemically eliminates bulky E-1,2-diferrocenylimine (E-3) via a formal 1,2-H shift from the N to the carbene C atom. Kinetic and mechanistic studies to the formation of imine E-3 are performed by NMR, IR and UV–vis spectroscopy and liquid injection field desorption ionization (LIFDI) mass spectrometry as well as by trapping experiments for low-coordinate tungsten complexes with triphenylphosphane. W(CO)5(E-2) decays thermally i…

tungstenIminemechanism010402 general chemistryPhotochemistry01 natural sciencesMedicinal chemistryReductive eliminationFull Research Paperlcsh:QD241-441chemistry.chemical_compoundlcsh:Organic chemistryAmideNucleophilic substitutionlcsh:Science010405 organic chemistryChemistryOrganic ChemistryferroceneOxidative addition0104 chemical sciencesChemistrycarbene complexesAlkoxy groupPseudorotationlcsh:QimineCarbeneBeilstein Journal of Organic Chemistry
researchProduct

Nanofilm Low Cost Oxygen Sensors

2009

Abstract The resitivity change of ultra thin metals under air exposure is used for vacuum or inert gas packaging control. In order to reach low cost, single use applications, few nm thin Aluminum layers were deposited on PET substrates and combined with wireless electronic readout circuitry. The sensor respose is characterized by resistance changes and explained in terms of multiphase diffusion mechanisms which are very sensitive to technological parameters.

ultrathin metalsMaterials scienceSingle useChemistry(all)technology industry and agriculturechemistry.chemical_elementNanotechnologyGeneral Medicineoxygen sensornanofilmAir exposurechemistryAluminiumChemical Engineering(all)sense organsDiffusion (business)Inert gasOxygen sensorProcedia Chemistry
researchProduct

Real-world experience with obeticholic acid in patients with primary biliary cholangitis

2021

Background & aims Obeticholic acid (OCA) is the second-line treatment approved for patients with primary biliary cholangitis (PBC) and an inadequate response or intolerance to ursodeoxycholic acid. We aimed to evaluate the effectiveness and safety of OCA under real-world conditions. Methods Patients were recruited into the Italian PBC Registry, a multicentre, observational cohort study that monitors patients with PBC at national level. The primary endpoint was the biochemical response according to Poise criteria; the secondary endpoint was the biochemical response according to normal range criteria, defined as normal levels of bilirubin, alkaline phosphatase (ALP), and alanine aminotransfer…

upper limit of normalCirrhosisALTAMAAutoimmunityantinuclear antibodiesULNPBCGastroenterologyUDCASettore MED/12ULN upper limit of normalobeticholic acidaRR adjusted risk ratio.CRFs case record formAST aspartate transferaseClinical endpointGGT gamma-glutamyl transferaseQCprimary biliary cholangitisGastroenterologyUrsodeoxycholic acidANATCCCirrhosisCholestasiTIPSTreatment Completer CohortANA antinuclear antibodiemedicine.medical_specialtyRRUDCA ursodeoxycholic acidTIPS transjugular intrahepatic portosystemic shuntOCACirrhosiALP alkaline phosphataseautoimmune hepatitismedicine.diseasedigestive system diseasesDiscontinuationKeywords: AIH autoimmune hepatitiQC quality controlchemistrygamma-glutamyl transferaserandomised controlled trialelectronic data captureantimitochondrial antibodiesaspartate transferaseAutoimmune hepatitischemistry.chemical_compoundAIHCRFsImmunology and Allergyadjusted risk ratioANA antinuclear antibodiesRR risk ratioOverall cohortALT alanine transferaseAMA antimitochondrial antibodieCholestasisCRFs case record formsObeticholic acidOverlap PBC-AIHursodeoxycholic acidOCA obeticholic acidTolerabilityalkaline phosphataseRCTResearch Articlemedicine.drugcase record formsContext (language use)AMA antimitochondrial antibodiesInternal medicineEDC electronic data capturetransjugular intrahepatic portosystemic shuntInternal MedicinemedicineRCT randomised controlled trialaRR adjusted risk ratioOClcsh:RC799-869quality controlalanine transferaseASTaRRHepatologybusiness.industryAutoimmunity; Cholestasis; Cirrhosis; Overlap PBC-AIHAIH autoimmune hepatitisTCC Treatment Completer CohortPBC primary biliary cholangitiGGTrisk ratioOC Overall cohortALPlcsh:Diseases of the digestive system. GastroenterologyPBC primary biliary cholangitisbusinessEDC
researchProduct